Glaxo to start diabetes drug Phase 3 trials

GlaxoSmithKline PLC said it had started large-scale Phase 3 clinical trials to evaluate the safety and efficacy of its Type 2 diabetes drug Syncria.

Newsletters Local U.S. and World Politics Weather Weather Alerts School Closings See It, Share It Sports Phillies Eagles Sixers Flyers NBC Sports Philadelphia Investigators NBC10 Responds Submit a tip Watch The Lineup Philly Live Entertainment
About NBC10 Philadelphia Our News Standards Share a News Tip or Feedback Share a Consumer Complaint Share Photos and Video Watch Live TV Community NBC Sports Philadelphia TV Schedule Our Apps Newsletters Contests Cozi TV
Contact Us